The treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases:
Lower Respiratory Tract Infections: Pneumonia caused by P. aeruginosa; H.influenzae including ampiciilin-resistant strains; Klebsiella species: Enterobacter species P. mirabilis: E. coli; Serratia species; S. pneumoniae; and S. aureus including ampicillin-resistant (but not methicillin-resistant) strains.
Urinary Tract infections: caused by P. aeruginosa; Enterobacter species; Proteus species (indole positive and negative); Klebsielia species and E. colt. Due to the nature of the underlying conditions which usually predispose patients to Pseudomonas infections of the lower respiratory and urinary tracts, a good clinical response accompanied by bacterial eradication may not be achieved despite evidence of in vitro sensitivity.
Skin Structure Infection: caused by P. aeruginosa; Klebsiella species; E. coli; P.mirabilis; enterohacter species; S. aureus. including ampicillin-resistant (but not methicillin-resistant) strains, and S. pyogenes.
Bacteremia/Septicemia: caused by P. aeruiginosa; Klebsiella specie’s: E colt: Serratia species: S. pneumoniae; S. aureus. including ampicillin-resistant (but not methicillin resistant) strains: and S. epiderinidis.
Bone Infections: caused by P. aeruginosa; P. mirabihs; Enterobacter species; and S. aureus. including ampicillin-resistant (but not methicillin-resistant) strains.
Peritonitis: caused by E. coil; Klebsiella species, and Peplostreptococcus species. Patients infected with Bacteroides species have ‘also responded.
Meningitis: caused by l-I. influenzae and N. meningitidis. Ceftazidime has also been used successfully in a limited number of cases of meningitis due to P. aeruginosa. Specimens for bacteriologic culture should be obtained prior to therapy in order to identify the causative organisms and to determine their susceptibilities to Ceftazidime.
Dosage Forms:
Each vial contains: Ceftazidime 250mg as Ceftazidime pentahydrate USP.
Each vial contains: Ceftazidime 500mg as Ceftazidime pentahydrate USP.